FDA Adverse Event Injury Summary report: N

XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEM

MDR report key: 1902115 · Received November 10, 2010

Report

Report Number
2024168-2010-02406
Event Type
Injury
Date Received
November 10, 2010
Date of Event
May 25, 2010
Report Date
October 20, 2010
Manufacturer
ABBOTT VASCULAR-CARDIAC THERAPIES
Product Code
NIQ
PMA / PMN Number
P070015
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
PA, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B)(4). THE STENT REMAINS IN THE PT. ANGINA, MYOCARDIAL INFARCTION (MR), AND RESTENOSIS ARE KNOWN ADVERSE EVENTS AS LISTED IN THE XIENCE V INSTRUCTIONS FOR USE. ALTHOUGH A CONCLUSIVE CAUSE FOR THE REPORTED PT EFFECTS AND THE RELATIONSHIP TO THE DEVICE, IF ANY, COULD NOT BE DETERMINED,THERE IS NO INDICATION OF A PRODUCT QUALITY DEFICIENCY WITH RESPECT TO MANUFACTURER OR DESIGN.

Description of Event or Problem · 1

IT WAS REPORTED VIA A TRAIL THAT ON (B)(6) 2008, THE PT UNDERWENT STENTING IN THE PREDILATED MID RIGHT CORONARY ARTERY WITH ONE XIENCE V STENT. ON (B)(6) 2010, THE PT EXPERIENCED EARLY MORNING CHEST PAIN OF MODERATE INTENSITY. THE PT TOOK SUBLINGUAL NITROGLYCERIN AND PHONED THE AMBULANCE. THE ELECTROCARDIOGRAM SHOWED A Q WAVE AND ST ELEVATION MYOCARDIAL INFARCTION. THE PT WAS HOSPITALIZED AND UNDERWENT PERCUTANEOUS CORONARY REVASCULARIZATION ON (B)(6) 2010 IN THE TARGET LESION AND IN THE NON-TARGET PROXIMAL LEFT CIRCUMFLEX ARTERY. THE PATIENT'S CONDITION RESOLVED AND WAS DISCHARGED ON (B)(6) 2010. THOUGH REQUESTED, NO ADDITIONAL INFO WAS PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEM NIQ ABBOTT VASCULAR-CARDIAC THERAPIES NA 8051361

Patients

Seq Age Sex Outcome Treatment
1 62 YR Hospitalization| R| S VESSEL CLOSURE: MANUAL COMPRESSION